According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...

On 20 January 2026, Ropes & Gray’s Global Life Sciences Regulatory & Compliance team hosted the “Life Sciences Regulatory Outlook 2026” webinar.

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Regulatory challenges have been even more top of mind than usual given recent upheaval at the FDA. BioSpace spoke to three industry experts about key issues, which include applying new artificial ...

PBM transparency reforms aim to lower drug costs, but their impact on competition depends on how they affect smaller and ...

Pharmaceutical products are essential for health, and they play and will continue to play a key role in disease prevention ...

India plans to place pregabalin under Schedule H1 to curb misuse. The move would mandate prescription-only sales, strict record-keeping, and tighter oversight while ensuring access for genuine ...

By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...

Advancements in drug manufacturing technologies are reshaping global regulatory frameworks. This shift is largely driven by the integration of artificial intelligence (AI)-powered models, cloud-based ...

The Annual Regulatory Plan for 2023 recently released by the Spanish Government provides for important regulatory changes and developments in the area of medicinal products, including pricing and ...

An interview with Dinesh Thakur and Prashant Reddy about India’s drug manufacturing industry and recent cases of India-made drugs leading to the deaths of children in Uzbekistan and Gambia. In India, ...